9 / 2016-01-01 02:39:36

微创玻璃体切割术治疗Terson综合征的疗效观察

9070

【摘要】 目的 探讨和评价23G Constellation玻璃体切割系统治疗Terson综合征的疗效和安全性。方法 回顾分析2014年6月-2015年6月11例(15只眼)，伴有玻璃体积血的Terson综合征患者，于玻璃体积血后1-4个月内行23G玻璃体切割术，术后6个月，观察患者最佳矫正视力、眼压、相对性瞳孔传入障碍、全自动视野、OCT黄斑及视神经纤维层解剖结构及视网膜在位情况。结果 所有患者术后最佳矫正视力较术前均有不同程度的提高，眼压正常，术前及术后均表现有RAPD（+）者3例，大多数（12/15）患者术前表现为中心视野遮挡，术后有明显改善，术后93%以上的黄斑及视网膜解剖结构在位。结论 23G玻璃体切割术治疗Terson综合征患者的玻璃体积血，安全有效。
【关键词】 Terson综合征；玻璃体切割术

【Abstract】 Objective To evaluate the efficacy and safety of minimally invasive vitrectomy for treatment of Terson ‘s syndrome. Methods From Jun. 2014 to Jun. 2015,11 patients(15 eyes) with Terson’s syndrome were analyzed retrospectively. The patients received 23G vitrectomy ( Constellation system). After 6 months, the effects were detected through best correct visual acuity, intraocular pressure, RAPD, Humphrey perimeter, macular structure and retinal nerve fiber layer thickness in OCT, retina reattachment situation. Results The improvement of postoperative best correct visual acuity was found in all patients for different degree, IOP normal, 3 eyes were found RAPD(+) preoperative or postoperative, most eyes showed center view shades and improved postoperative, more than 93% eyes got anatomical recovery of macular and retinal nerve layer thickness. Conclusions It is effective and safe that minimally invasive vitrectomy for treatment of Terson’s syndrome.
【Key words】 Terson’s syndrome; minimally invasive vitrectomy